These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10013 related articles for article (PubMed ID: 14110908)

  • 1. QUANTITATIVE DETERMINATION OF DOPA; ITS APPLICATION TO MEASUREMENT OF DOPA IN URINE AND IN THE ASSAY OF TYROSINASE IN SERUM.
    TAKAHASHI H; FITZPATRICK TB
    J Invest Dermatol; 1964 Jan; 42():161-5. PubMed ID: 14110908
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECT OF VARIOUS PSYCHOTROPIC DRUGS ON THE ACTIVITY OF TYROSINASE.
    WENDE CV
    Biochem Pharmacol; 1965 Apr; 14():631-3. PubMed ID: 14329275
    [No Abstract]   [Full Text] [Related]  

  • 3. [BIOCHEMISTRY OF TYROSINASE].
    LEONHARDI G; LOEHNER L
    Arch Klin Exp Dermatol; 1964 Jun; 219():790-4. PubMed ID: 14237741
    [No Abstract]   [Full Text] [Related]  

  • 4. DROSOPHILA PHENOL OXIDASES.
    MITCHELL HK; WEBER UM
    Science; 1965 May; 148(3672):964-5. PubMed ID: 14277838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inability of murine melanoma "tyrosinase" (dopa ozidase) to oxidize tyrosine in the presence or absence of dopa or dihydroxyfumarate cofactor.
    Patel RP; Okun MR; Yee WA; Wilgram GF; Edelstein LM
    J Invest Dermatol; 1973 Aug; 61(2):55-9. PubMed ID: 4199461
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDY OF TYROSINASE ACTIVITY CHANGES IN EXPERIMENTAL MOUSE MELANOMA S 91 UNDER THE INFLUENCE OF TESTOSTERONE].
    DELACRETAZ J
    Ann Dermatol Syphiligr (Paris); 1965; 92():25-8. PubMed ID: 14295922
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosinase exhibits lag at pH 6.8 under steady state concentrations of tyrosine and 3,4-dihydroxy phenyl alanine in melanoma tissue.
    Chintamaneni C; Nadimpalli AR; Abburi R
    Indian J Biochem Biophys; 1991; 28(5-6):408-11. PubMed ID: 1812074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AN ENZYMATIC AND ELECTRON MICROSCOPIC CHARACTERIZATION OF A VARIANT OF THE CLOUDMAN S-91 MELANOMA.
    HIRSCH HM; ZELICKSON AS
    Cancer Res; 1964 Aug; 24():1137-53. PubMed ID: 14216148
    [No Abstract]   [Full Text] [Related]  

  • 10. A PROCEDURE WHICH DEMONSTRATES SUBSTRATE INHIBITION OF TYROSINASE.
    KEAN EA
    Biochim Biophys Acta; 1964 Dec; 92():602-4. PubMed ID: 14264893
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE COUPLED OXIDATION OF 1,4-BENZENEDIOL AND ASCORBIC ACID BY POTATO TYROSINASE. MECHANISM OF THE REACTION].
    LEGRAND G; NEUMANN J; LEHONGRE G
    Bull Soc Chim Biol (Paris); 1963 Nov; 45():1159-70. PubMed ID: 14095834
    [No Abstract]   [Full Text] [Related]  

  • 12. New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase.
    Winder AJ; Harris H
    Eur J Biochem; 1991 Jun; 198(2):317-26. PubMed ID: 1674912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin.
    Körner A; Pawelek J
    Science; 1982 Sep; 217(4565):1163-5. PubMed ID: 6810464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphonic and phosphinic acid analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) as potential antimelanotic agents.
    Lejczak B; Duś D; Kafarski P
    Anticancer Drug Des; 1990 Nov; 5(4):351-8. PubMed ID: 2127180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of drugs for dopa-auto-oxidation melanin and tyrosinase-catalyzed dopa-melanin in vitro.
    Hayasaka S; Tsuchiya M; Noda S; Setogawa T; Mizuno K
    Ophthalmic Res; 1988; 20(6):376-9. PubMed ID: 3148876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative determination of phenoloxidase (EC 1.14.18.1). Spectrophotometry measurement of the activity of mushroom and potato tyrosinase].
    Schmidt H
    Dermatol Monatsschr; 1990; 176(12):757-61. PubMed ID: 2128830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of tyrosinase by dopa.
    Tomita Y; Hariu A; Mizuno C; Seiji M
    J Invest Dermatol; 1980 Nov; 75(5):379-82. PubMed ID: 6776205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine.
    Yamazaki Y; Kawano Y
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1536-40. PubMed ID: 21048351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of 6-hydroxydopa by human tyrosinase.
    Hansson C; Rorsman H; Rosengren E; Wittbjer A
    Acta Derm Venereol; 1985; 65(2):154-7. PubMed ID: 2408419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
    Ito S; Kato T; Shinpo K; Fujita K
    Biochem J; 1984 Sep; 222(2):407-11. PubMed ID: 6433900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 501.